0001127602-17-032183.txt : 20171115 0001127602-17-032183.hdr.sgml : 20171115 20171115160952 ACCESSION NUMBER: 0001127602-17-032183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171113 FILED AS OF DATE: 20171115 DATE AS OF CHANGE: 20171115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sheridan William P CENTRAL INDEX KEY: 0001439174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 171205324 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-11-13 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001439174 Sheridan William P 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior VP - CMO Common Stock 2017-11-13 4 S 0 64310 4.72 D 23855 D This transaction was made pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person and represents approximately 6 percent of the reporting person's pre-sale vested and unvested holdings. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.65 to $4.78. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ Alane P. Barnes, by power of attorney 2017-11-15